Skip to main content
. 2022 Oct 28;10(11):2747. doi: 10.3390/biomedicines10112747

Figure 2.

Figure 2

Figure 2

HSP90 inhibition downregulates CD4 and CD8 surface expression. HSP90 inhibitor downregulates surface expression of CD4 (A) and CD8 (B). T cells were incubated for 4 days with allogeneic mo-DCs in the presence or absence of 0.1 µM geldanamycin (GA). (C) Representative flow cytometry plots showing downregulation of CD4 and CD8 molecules on the surface of T cells in response to GA in MLR. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01.